Medpace Holdings IncNASDAQ:MEDP
- LAST PRICE395.9300
- TODAY'S CHANGE (%)6.1600 (1.5804%)
- Bid / Lots338.8800/ 5
- Ask / Lots627.5100/ 1
- Open / Previous Close391.7200 / 389.7700
- Day Range
- 52 Week Range
- Volume144,681
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MEDP |
|---|---|---|
| 09:32 ET | 1167 | 391.72 |
| 09:39 ET | 100 | 393.415 |
| 09:41 ET | 100 | 393.9 |
| 09:43 ET | 440 | 392.3 |
| 09:48 ET | 193 | 395.79 |
| 09:50 ET | 300 | 393.75 |
| 09:54 ET | 200 | 395.3 |
| 09:56 ET | 300 | 395.24 |
| 09:57 ET | 100 | 394.36 |
| 09:59 ET | 200 | 395 |
| 10:01 ET | 300 | 394.1 |
| 10:03 ET | 875 | 393.8 |
| 10:06 ET | 396 | 393.035 |
| 10:08 ET | 200 | 390.265 |
| 10:10 ET | 200 | 391.64 |
| 10:12 ET | 222 | 392.23 |
| 10:14 ET | 200 | 392.6 |
| 10:15 ET | 109 | 392.25 |
| 10:17 ET | 320 | 392.65 |
| 10:19 ET | 100 | 391.85 |
| 10:21 ET | 200 | 391.59 |
| 10:24 ET | 400 | 392.29 |
| 10:28 ET | 100 | 391.99 |
| 10:32 ET | 100 | 391.09 |
| 10:35 ET | 100 | 391.55 |
| 10:37 ET | 700 | 392.37 |
| 10:39 ET | 2231 | 391.6 |
| 10:42 ET | 200 | 392.71 |
| 10:50 ET | 100 | 393.105 |
| 10:53 ET | 502 | 392.875 |
| 10:57 ET | 100 | 392.015 |
| 11:00 ET | 207 | 392.53 |
| 11:04 ET | 100 | 391.56 |
| 11:08 ET | 1001 | 390.525 |
| 11:11 ET | 200 | 389.455 |
| 11:13 ET | 300 | 389.63 |
| 11:18 ET | 182 | 389.935 |
| 11:24 ET | 100 | 389.42 |
| 11:26 ET | 400 | 389.77 |
| 11:27 ET | 2200 | 390.01 |
| 11:29 ET | 3290 | 390.54 |
| 11:33 ET | 100 | 390.445 |
| 11:36 ET | 100 | 390.485 |
| 11:38 ET | 200 | 390.145 |
| 11:49 ET | 100 | 389.77 |
| 11:51 ET | 200 | 390.04 |
| 11:58 ET | 100 | 390.68 |
| 12:00 ET | 100 | 390.68 |
| 12:02 ET | 500 | 392.04 |
| 12:03 ET | 100 | 392.785 |
| 12:07 ET | 127 | 392.5383 |
| 12:12 ET | 475 | 392.6131 |
| 12:14 ET | 200 | 393.75 |
| 12:16 ET | 100 | 393.81 |
| 12:20 ET | 100 | 392.94 |
| 12:27 ET | 200 | 393.17 |
| 12:30 ET | 300 | 393 |
| 12:32 ET | 100 | 393.13 |
| 12:34 ET | 200 | 393.335 |
| 12:39 ET | 100 | 393.08 |
| 12:48 ET | 100 | 393.23 |
| 12:50 ET | 300 | 392.32 |
| 12:52 ET | 100 | 392.53 |
| 12:54 ET | 1051 | 393.15 |
| 12:56 ET | 100 | 393.14 |
| 12:57 ET | 100 | 393.13 |
| 12:59 ET | 100 | 393.125 |
| 01:01 ET | 600 | 393.395 |
| 01:03 ET | 100 | 393.355 |
| 01:06 ET | 200 | 395.08 |
| 01:14 ET | 100 | 394.9 |
| 01:19 ET | 500 | 396.68 |
| 01:21 ET | 100 | 395.725 |
| 01:24 ET | 100 | 396.63 |
| 01:26 ET | 100 | 396.245 |
| 01:28 ET | 200 | 396.16 |
| 01:30 ET | 100 | 396.54 |
| 01:32 ET | 309 | 396.18 |
| 01:33 ET | 1510 | 396.59 |
| 01:35 ET | 1400 | 397.05 |
| 01:37 ET | 900 | 396.1 |
| 01:42 ET | 230 | 393.5 |
| 01:44 ET | 500 | 394.35 |
| 01:51 ET | 215 | 395.1 |
| 02:06 ET | 100 | 395.22 |
| 02:09 ET | 200 | 395.14 |
| 02:11 ET | 100 | 394.94 |
| 02:18 ET | 100 | 395.2 |
| 02:22 ET | 100 | 395.45 |
| 02:29 ET | 100 | 394.77 |
| 02:31 ET | 266 | 394.66 |
| 02:40 ET | 100 | 394.54 |
| 02:56 ET | 200 | 395.81 |
| 02:58 ET | 100 | 396.08 |
| 03:02 ET | 1800 | 395.845 |
| 03:07 ET | 100 | 394.89 |
| 03:23 ET | 100 | 394.63 |
| 03:30 ET | 100 | 394.8 |
| 03:32 ET | 500 | 394.67 |
| 03:38 ET | 300 | 393.91 |
| 03:41 ET | 569 | 394.49 |
| 03:43 ET | 300 | 394.69 |
| 03:45 ET | 300 | 394.56 |
| 03:50 ET | 200 | 394.665 |
| 03:52 ET | 766 | 395.05 |
| 03:54 ET | 517 | 396 |
| 03:56 ET | 614 | 396.205 |
| 03:57 ET | 345 | 396.025 |
| 03:59 ET | 23302 | 395.93 |
Apr 24, 2024
DJ Medpace Holdings Is Maintained at Buy by Guggenheim, from 1:52PM ET on Wednesday Apr 24, 2024 by Dow Jones
1:52PM ET on Wednesday Apr 24, 2024 by Dow JonesDJ Medpace Holdings Is Maintained at Outperform by Baird, from 7:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
7:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 23, 2024
DJ Medpace Holdings Raised to Buy From Hold by Jefferies, from 11:18AM ET on Tuesday Apr 23, 2024 by Dow Jones
11:18AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 22, 2024
*DJ Medpace Holdings 1Q EPS $3.20 >MEDP, from 4:15PM ET on Monday Apr 22, 2024 by Dow Jones
4:15PM ET on Monday Apr 22, 2024 by Dow JonesMedpace Holdings, Inc. Reports First Quarter 2024 Results, from 4:15PM ET on Monday Apr 22, 2024 by Dow Jones
4:15PM ET on Monday Apr 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medpace Holdings Inc | 12.1B | 40.3x | +35.10% |
Neurocrine Biosciences Inc | 13.9B | 55.9x | +62.04% |
Qiagen NV | 9.1B | 27.3x | +12.66% |
United Therapeutics Corp | 11.1B | 11.8x | +8.22% |
Sarepta Therapeutics Inc | 12.0B | -20.9x | --- |
Exact Sciences Corp | 10.7B | -51.8x | --- |
Company Information
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Contact Information
- Headquarters
- 5375 Medpace WayCINCINNATI, OH, United States 45227-1543
- Phone
- 513-579-9911
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- August Troendle
- President
- Jesse Geiger
- Chief Financial Officer, Treasurer
- Kevin Brady
- Executive Vice President - Operations
- Susan Burwig
- General Counsel, Corporate Secretary
- Stephen Ewald
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.1B |
|---|---|
Revenue (TTM) | $2.0B |
Shares Outstanding | 31.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $9.81 |
Book Value | $18.22 |
P/E Ratio | 40.3x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | 35.5x |
Operating Margin | 18.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
